QUIPT HOME MEDICAL CORP (QIPT) Stock Fundamental Analysis
NASDAQ:QIPT - Nasdaq - CA74880P1045 - Common Stock - Currency: USD
QIPT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 103 industry peers in the Health Care Providers & Services industry. QIPT has a bad profitability rating. Also its financial health evaluation is rather negative. QIPT is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year QIPT has reported negative net income.
QIPT had a positive operating cash flow in the past year.
In the past 5 years QIPT reported 4 times negative net income.
QIPT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
QIPT has a worse Return On Assets (-2.99%) than 60.19% of its industry peers.
QIPT has a Return On Equity of -6.83%. This is comparable to the rest of the industry: QIPT outperforms 43.69% of its industry peers.
QIPT has a Return On Invested Capital of 0.14%. This is comparable to the rest of the industry: QIPT outperforms 40.78% of its industry peers.
The Average Return On Invested Capital over the past 3 years for QIPT is significantly below the industry average of 9.72%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.99% | ||
| ROE | -6.83% | ||
| ROIC | 0.14% |
ROA(3y)-0.08%
ROA(5y)-2.47%
ROE(3y)-0.93%
ROE(5y)-5.94%
ROIC(3y)2.55%
ROIC(5y)N/A
1.3 Margins
Looking at the Operating Margin, with a value of 0.14%, QIPT is in line with its industry, outperforming 40.78% of the companies in the same industry.
QIPT's Gross Margin of 71.56% is amongst the best of the industry. QIPT outperforms 88.35% of its industry peers.
QIPT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.14% | ||
| PM (TTM) | N/A | ||
| GM | 71.56% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.23%
GM growth 5Y-0.04%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so QIPT is destroying value.
The number of shares outstanding for QIPT has been increased compared to 1 year ago.
Compared to 5 years ago, QIPT has more shares outstanding
The debt/assets ratio for QIPT is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.50, we must say that QIPT is in the distress zone and has some risk of bankruptcy.
QIPT has a Altman-Z score of 0.50. This is in the lower half of the industry: QIPT underperforms 75.73% of its industry peers.
QIPT has a debt to FCF ratio of 4.91. This is a neutral value as QIPT would need 4.91 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.91, QIPT is in the better half of the industry, outperforming 66.99% of the companies in the same industry.
QIPT has a Debt/Equity ratio of 0.74. This is a neutral value indicating QIPT is somewhat dependend on debt financing.
QIPT has a Debt to Equity ratio (0.74) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.74 | ||
| Debt/FCF | 4.91 | ||
| Altman-Z | 0.5 |
ROIC/WACC0.02
WACC8.48%
2.3 Liquidity
QIPT has a Current Ratio of 1.22. This is a normal value and indicates that QIPT is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.22, QIPT is doing worse than 62.14% of the companies in the same industry.
A Quick Ratio of 0.87 indicates that QIPT may have some problems paying its short term obligations.
With a Quick ratio value of 0.87, QIPT is not doing good in the industry: 70.87% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.22 | ||
| Quick Ratio | 0.87 |
3. Growth
3.1 Past
The earnings per share for QIPT have decreased strongly by -80.00% in the last year.
Looking at the last year, QIPT shows a quite strong growth in Revenue. The Revenue has grown by 10.92% in the last year.
The Revenue has been growing by 32.16% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-80%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
Revenue 1Y (TTM)10.92%
Revenue growth 3Y33.91%
Revenue growth 5Y32.16%
Sales Q2Q%-10.29%
3.2 Future
Based on estimates for the next years, QIPT will show a very strong growth in Earnings Per Share. The EPS will grow by 97.77% on average per year.
Based on estimates for the next years, QIPT will show a very strong growth in Revenue. The Revenue will grow by 21.85% on average per year.
EPS Next Y32%
EPS Next 2Y20.9%
EPS Next 3Y16.35%
EPS Next 5Y97.77%
Revenue Next Year-3.59%
Revenue Next 2Y0.8%
Revenue Next 3Y1.65%
Revenue Next 5Y21.85%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
QIPT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for QIPT. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, QIPT is valued cheaply inside the industry as 93.20% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, QIPT is valued cheaper than 96.12% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.7 | ||
| EV/EBITDA | 4.18 |
4.3 Compensation for Growth
QIPT's earnings are expected to grow with 16.35% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.9%
EPS Next 3Y16.35%
5. Dividend
5.1 Amount
No dividends for QIPT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:QIPT (7/28/2025, 10:24:10 AM)
2.22
-0.01 (-0.45%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners45.65%
Inst Owner Change-4.29%
Ins Owners15.15%
Ins Owner Change53.95%
Market Cap96.44M
Analysts82
Price Target5.2 (134.23%)
Short Float %3.14%
Short Ratio0.89
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-45.98%
Min EPS beat(2)-124.09%
Max EPS beat(2)32.12%
EPS beat(4)1
Avg EPS beat(4)-255.78%
Min EPS beat(4)-540.96%
Max EPS beat(4)32.12%
EPS beat(8)1
Avg EPS beat(8)-522.14%
EPS beat(12)3
Avg EPS beat(12)-242.54%
EPS beat(16)4
Avg EPS beat(16)-226.56%
Revenue beat(2)0
Avg Revenue beat(2)-11.63%
Min Revenue beat(2)-20.53%
Max Revenue beat(2)-2.74%
Revenue beat(4)0
Avg Revenue beat(4)-7.82%
Min Revenue beat(4)-20.53%
Max Revenue beat(4)-2.74%
Revenue beat(8)1
Avg Revenue beat(8)-4.62%
Revenue beat(12)1
Avg Revenue beat(12)-4.57%
Revenue beat(16)2
Avg Revenue beat(16)-4.02%
PT rev (1m)-1.41%
PT rev (3m)-20.3%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.4 | ||
| P/FCF | 4.7 | ||
| P/OCF | 2.93 | ||
| P/B | 0.91 | ||
| P/tB | N/A | ||
| EV/EBITDA | 4.18 |
EPS(TTM)-0.18
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)0.47
FCFY21.28%
OCF(TTM)0.76
OCFY34.16%
SpS5.57
BVpS2.45
TBVpS-0.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.99% | ||
| ROE | -6.83% | ||
| ROCE | 0.18% | ||
| ROIC | 0.14% | ||
| ROICexc | 0.15% | ||
| ROICexgc | 0.5% | ||
| OM | 0.14% | ||
| PM (TTM) | N/A | ||
| GM | 71.56% | ||
| FCFM | 8.48% |
ROA(3y)-0.08%
ROA(5y)-2.47%
ROE(3y)-0.93%
ROE(5y)-5.94%
ROIC(3y)2.55%
ROIC(5y)N/A
ROICexc(3y)2.81%
ROICexc(5y)N/A
ROICexgc(3y)9.78%
ROICexgc(5y)N/A
ROCE(3y)3.22%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.23%
GM growth 5Y-0.04%
F-Score3
Asset Turnover1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.74 | ||
| Debt/FCF | 4.91 | ||
| Debt/EBITDA | 1.82 | ||
| Cap/Depr | 28.74% | ||
| Cap/Sales | 5.13% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 75.63% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.22 | ||
| Quick Ratio | 0.87 | ||
| Altman-Z | 0.5 |
F-Score3
WACC8.48%
ROIC/WACC0.02
Cap/Depr(3y)26.65%
Cap/Depr(5y)21.79%
Cap/Sales(3y)4.61%
Cap/Sales(5y)3.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-80%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
EPS Next Y32%
EPS Next 2Y20.9%
EPS Next 3Y16.35%
EPS Next 5Y97.77%
Revenue 1Y (TTM)10.92%
Revenue growth 3Y33.91%
Revenue growth 5Y32.16%
Sales Q2Q%-10.29%
Revenue Next Year-3.59%
Revenue Next 2Y0.8%
Revenue Next 3Y1.65%
Revenue Next 5Y21.85%
EBIT growth 1Y-93.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1615.9%
EBIT Next 3Y157.9%
EBIT Next 5Y154.85%
FCF growth 1Y23.94%
FCF growth 3Y22.49%
FCF growth 5Y24.98%
OCF growth 1Y26.48%
OCF growth 3Y23.7%
OCF growth 5Y33.42%